Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Most practitioners recommend discontinuing treatment while pregnant or nursing
GHK-Cu possesses significant anti-inflammatory properties, reducing the production of pro-inflammatory cytokines
This class of medications contains the popular semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
In vitro studies have documented 40-70% reductions in pro-inflammatory cytokine production, including TNF-alpha, IL-1beta, and IL-6, when inflammatory cells are pre-treated with GHK-Cu (1-5 M) prior to activation with lipopolysaccharide or other inflammatory stimuli
Amylin-receptor signaling models: Investigating receptor activation, downstream signal transduction, and neuroendocrine pathway engagement in controlled laboratory systems Energy-balance and ingestive-behavior research: Studying central and peripheral signaling mechanisms associated with nutrient sensing and metabolic regulation Glucose-homeostasis pathway research: Evaluating biomarker modulation and signaling stability in glucose-regulatory experimental models Multi-hormonal signaling frameworks: Examining coordinated pathway activity across amylin-related and complementary metabolic signaling systems in pre-clinical research Condensed Research Summary Cagrilintide is studied in laboratory models as a Satiety Signal Mapper to explore how amylin-mediated pathways influence neuroendocrine communication
US$ 26.38
US$ 29.82
US$ 28.18
US$ 23.85
